Last reviewed · How we verify

Transthyretin related familial amyloid cardiomyopathy

4 treatments

Approved treatments

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Frequently asked questions about Transthyretin related familial amyloid cardiomyopathy

What drugs treat Transthyretin related familial amyloid cardiomyopathy?

Tracked treatments include Vyndaqel.

What is the treatment for Transthyretin related familial amyloid cardiomyopathy?

Standard treatment for Transthyretin related familial amyloid cardiomyopathy includes Vyndaqel. See the treatment landscape page for first-line, second-line and salvage options.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing